Coya Therapeutics Inc Revenue per Employee (COYA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Coya Therapeutics Inc   (NASDAQ: COYA)
 

Coya Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Coya Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,002,393, below the company average number of $871,613.
Within the Healthcare sector Employees of 78 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 865, from total ranking in previous quarter at 1099. Coya Therapeutics Inc has 8 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COYA Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 48.97 % -2.61 % 202768.8 % - -95.22 %
Sales per Employee (TTM) $ 1,002,393 992,377 993,219 498,463 52,932
COYA's Total Ranking # 865 # 1099 # 1614 # #
Seq. Revenue Change -2.95 % -93.66 % 11.1 % 2078.43 % -36.55 %

COYA Company Profile >> Back to COYA Efficiency Comparisons >> Compare COYA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 55
Healthcare Sector # 79
Overall Market # 865

Revenue per Employee Statistics
High Average Low
$ 1,002,393 $ 871,613 $ 498,463
(Jun 30 2026)   (Sep 30 2025)



Financial Statements
Coya Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit COYA's Income Statement
Coya Therapeutics Inc 's Revenues TTM $ 8 Millions Visit COYA's aggregate revenue growth
What are COYA's Sales? Visit COYA's Sales by Segment




Other Ratios
Coya Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
COYA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for COYA's Competitors
Revenue per Employee for COYA's Suppliers
Revenue per Employee for COYA's Customers

You may also want to know
COYA's Sales Growth Rates COYA's Pe Price to earnings ratio COYA's Receivables Turnover Ratio COYA's Stock Quote
COYA's Net Income Growth Rates COYA's Ps Price to Sales ratio COYA's Sales per Employee COYA's Asset Turnover Ratio
COYA's Net Margin COYA's Pb Price to Book ratio COYA's Financial Strength Ratios COYA's Dividend Payout Ratio
Date modified: 2026-09-05T15:03:17+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million 2 
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Akebia Therapeutics Inc   1,129,175.26 $ 219.060  Million 194 
Siga Technologies Inc  1,095,079.92 $ 53.659  Million 49 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million 8 
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Evolus Inc   949,440.12 $ 317.113  Million 334 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.